Exact Mass: 343.3529

Exact Mass Matches: 343.3529

Found 30 metabolites which its exact mass value is equals to given mass value 343.3529, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Acetylsphinganine

N-(1,3-Dihydroxyoctadecan-2-yl)ethanimidate

C20H41NO3 (343.3086)


   

Senepodine B

Senepodine B

C23H39N2+ (343.3113)


   

(+)-3-deoxybuxandonine

(+)-3-deoxybuxandonine

C24H41N (343.3239)


   

C2 Dihydroceramide

C2 Dihydroceramide

C20H41NO3 (343.3086)


   

C15DEA

C15DEA

C20H41NO3 (343.3086)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); May be an alkyl homologue; Digitised from figure: approximate intensities

   

Dihydroceramide C2

Dihydroceramide C2

C20H41NO3 (343.3086)


   

Behenic acid(d3)

Docosanoic acid(d3)

C22H41D3O2 (343.3529)


   

SPB 21:0;O2

iso (19-methyl-d20:0) sphinganine

C21H45NO2 (343.345)


   

cedefingol

cedefingol

C20H41NO3 (343.3086)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

   

N,N-Bis(2-hydroxyethyl)hexadecanamide

N,N-bis(2-hydroxyethyl)hexadecan-1-amide

C20H41NO3 (343.3086)


   

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

C20H41NO3 (343.3086)


   

Ethanolamine oleate

monoethanolamine oleate

C20H41NO3 (343.3086)


C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy > C05BB - Sclerosing agents for local injection D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions C78275 - Agent Affecting Blood or Body Fluid D002317 - Cardiovascular Agents

   

N-Acetylsphinganine

N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]acetamide

C20H41NO3 (343.3086)


A dihydroceramide in which the ceramide acyl group is specified as acetyl.

   

2-Aminohenicosane-1,3-diol

2-Aminohenicosane-1,3-diol

C21H45NO2 (343.345)


   

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyundecan-2-yl)nonanamide

N-(1,3-dihydroxyundecan-2-yl)nonanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxynonan-2-yl)undecanamide

N-(1,3-dihydroxynonan-2-yl)undecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytridecan-2-yl)heptanamide

N-(1,3-dihydroxytridecan-2-yl)heptanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydodecan-2-yl)octanamide

N-(1,3-dihydroxydodecan-2-yl)octanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydecan-2-yl)decanamide

N-(1,3-dihydroxydecan-2-yl)decanamide

C20H41NO3 (343.3086)


   

Sphingosine (t20:1)

SPH(t20:1)

C20H41NO3 (343.3086)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

C24H41N (343.3239)


   

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

C24H41N (343.3239)


   

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

C20H41NO3 (343.3086)


   

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

C20H41NO3 (343.3086)


   

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

[C23H39N2]+ (343.3113)